EUVIMEDEUVIMED entdecken
Editorial

AI prescribing: clinical oversight must not be removed without robust evidence

Perisa Ashar, Mateen Abbasi, Imeth Illamperuma, Dang Nguyen, Ethan Lowder

BMJ · 13.11.2026 · 395 · e101445

DOI: 10.1136/bmj-2026-101445 ↗

Kurz gefasst

Editorial in der Zeitschrift BMJ, online erschienen am 13.11.2026. Verfasst von Perisa Ashar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Georgia Institute of Technology, Atlanta, GA, USA. Die Arbeit nennt 9 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A pilot in Utah could allow an AI tool to prescribe acne treatment with limited input from doctors, but evidence justifying its use must withstand scrutiny

Autor:innen und Institutionen

  • Georgia Institute of Technology, Atlanta, GA, USA.
  • Rutgers University, New Brunswick, NJ, USA.
  • McMaster University, Hamilton, ON, Canada.
  • Harvard TH Chan School of Public Health, Boston, MA, USA.
  • University of California, San Francisco, CA, USA.

Zitieren

APA

Ashar, P., Abbasi, M., Illamperuma, I., Nguyen, D., & Lowder, E. (2026). AI prescribing: clinical oversight must not be removed without robust evidence. BMJ, 395, e101445. https://doi.org/10.1136/bmj-2026-101445

Vancouver

Ashar P, Abbasi M, Illamperuma I, Nguyen D, Lowder E. AI prescribing: clinical oversight must not be removed without robust evidence. BMJ. 2026;395:e101445. doi:10.1136/bmj-2026-101445

BibTeX
@article{Ashar2026,
  author = {Ashar, Perisa and Abbasi, Mateen and Illamperuma, Imeth and Nguyen, Dang and Lowder, Ethan},
  title = {AI prescribing: clinical oversight must not be removed without robust evidence},
  journal = {BMJ},
  year = {2026},
  volume = {395},
  pages = {e101445},
  doi = {10.1136/bmj-2026-101445}
}
Kostenlos starten →